CEL-SCI CORPORATION Increase (Decrease) in Accrued Liabilities
CEL-SCI CORPORATION (CVM) reported Increase (Decrease) in Accrued Liabilities of -$259.70 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$7.10K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$26.24K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$226.36K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $181.22K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for fiscal 2025 was $120.73K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for fiscal 2024 was -$458.49K, a 321.40% decline from fiscal 2023.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for fiscal 2023 was $207.09K.
- CEL-SCI CORPORATION increase (decrease) in accrued liabilities for fiscal 2022 was -$16.72K, a 104.60% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$33.34K derived: sum of 2 quarters · filed 2026-08-14 | -$259.70K 10-Q · filed 2026-08-14 | -$78.48K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$26.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$252.60K 10-Q · filed 2026-05-15 | -$71.38K derived: sum of 3 quarters · filed 2026-05-15 | -$92.33K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$226.36K 10-Q · filed 2026-02-17 | -$45.14K derived: sum of 2 quarters · filed 2026-02-17 | -$66.09K derived: sum of 3 quarters · filed 2026-08-14 | -$90.34K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $181.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $160.27K derived: sum of 2 quarters · filed 2026-08-14 | $136.02K derived: sum of 3 quarters · filed 2026-08-14 | $120.73K 10-K · filed 2025-12-29 |
| 2025-06-30 | -$20.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$45.20K derived: sum of 2 quarters · filed 2026-08-14 | -$60.49K 10-Q · filed 2026-08-14 | -$686.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$24.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$39.54K 10-Q · filed 2026-05-15 | -$665.60K derived: sum of 3 quarters · filed 2026-05-15 | -$557.85K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$15.29K 10-Q · filed 2026-02-17 | -$641.35K derived: sum of 2 quarters · filed 2026-02-17 | -$533.60K derived: sum of 3 quarters · filed 2026-02-17 | -$464.86K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | -$626.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$518.31K derived: sum of 2 quarters · filed 2025-12-29 | -$449.56K derived: sum of 3 quarters · filed 2025-12-29 | -$458.49K 10-K · filed 2025-12-29 |
| 2024-06-30 | $107.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $176.49K derived: sum of 2 quarters · filed 2025-08-14 | $167.57K 10-Q · filed 2025-08-14 | $130.86K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $68.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $59.82K 10-Q · filed 2025-05-14 | $23.11K derived: sum of 3 quarters · filed 2025-05-14 | $155.39K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$8.92K 10-Q · filed 2025-02-14 | -$45.63K derived: sum of 2 quarters · filed 2025-02-14 | $86.65K derived: sum of 3 quarters · filed 2025-02-14 | $184.82K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | -$36.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | $95.57K derived: sum of 2 quarters · filed 2025-01-13 | $193.74K derived: sum of 3 quarters · filed 2025-01-13 | $207.09K 10-K · filed 2025-01-13 |
| 2023-06-30 | $132.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $230.45K derived: sum of 2 quarters · filed 2024-08-14 | $243.80K 10-Q · filed 2024-08-14 | $148.35K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $98.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | $111.52K 10-Q · filed 2024-05-15 | $16.06K derived: sum of 3 quarters · filed 2024-05-15 | $5.64K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $13.35K 10-Q · filed 2024-02-14 | -$82.11K derived: sum of 2 quarters · filed 2024-02-14 | -$92.53K derived: sum of 3 quarters · filed 2024-02-14 | -$99.06K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$95.45K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$105.87K derived: sum of 2 quarters · filed 2023-12-21 | -$112.41K derived: sum of 3 quarters · filed 2023-12-21 | -$16.72K 10-K · filed 2023-12-21 |
| 2022-06-30 | -$10.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | -$16.96K derived: sum of 2 quarters · filed 2023-08-10 | $78.73K 10-Q · filed 2023-08-10 | $144.50K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$6.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $89.15K 10-Q · filed 2023-05-12 | $154.92K derived: sum of 3 quarters · filed 2023-05-12 | $595.59K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $95.69K 10-Q · filed 2023-02-14 | $161.46K derived: sum of 2 quarters · filed 2023-02-14 | $602.13K derived: sum of 3 quarters · filed 2023-02-14 | $316.36K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $65.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | $506.44K derived: sum of 2 quarters · filed 2022-12-27 | $220.67K derived: sum of 3 quarters · filed 2022-12-27 | $363.70K 10-K · filed 2022-12-27 |
| 2021-06-30 | $440.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $154.90K derived: sum of 2 quarters · filed 2022-08-12 | $297.93K 10-Q · filed 2022-08-12 | $616.19K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$285.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$142.74K 10-Q · filed 2022-05-13 | $175.52K derived: sum of 3 quarters · filed 2022-05-13 | $243.23K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $143.03K 10-Q · filed 2022-02-11 | $461.29K derived: sum of 2 quarters · filed 2022-02-11 | $529.00K derived: sum of 3 quarters · filed 2022-02-11 | $468.68K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | $318.26K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $385.97K derived: sum of 2 quarters · filed 2021-12-21 | $325.65K derived: sum of 3 quarters · filed 2021-12-21 | $406.08K 10-K · filed 2021-12-21 |
| 2020-06-30 | $67.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $7.39K derived: sum of 2 quarters · filed 2021-08-13 | $87.82K 10-Q · filed 2021-08-13 | $30.22K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$60.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $20.11K 10-Q · filed 2021-05-17 | -$37.49K derived: sum of 3 quarters · filed 2021-05-17 | -$233.35K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $80.43K 10-Q · filed 2021-02-12 | $22.83K derived: sum of 2 quarters · filed 2021-02-12 | -$173.03K derived: sum of 3 quarters · filed 2021-02-12 | $37.15K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-09-30 | -$57.60K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | -$253.46K derived: sum of 2 quarters · filed 2020-12-31 | -$43.28K derived: sum of 3 quarters · filed 2020-12-31 | -$170.88K 10-K · filed 2020-12-29 |
| 2019-06-30 | -$195.86K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $14.32K derived: sum of 2 quarters · filed 2020-12-31 | -$113.28K 10-Q/A · filed 2020-12-31 | -$769.81K derived: sum of 4 quarters · filed 2020-12-31 |
| 2019-03-31 | $210.18K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | $82.58K 10-Q/A · filed 2020-12-30 | -$573.95K derived: sum of 3 quarters · filed 2020-12-30 | -$614.84K derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-12-31 | -$127.60K 10-Q/A · filed 2020-12-30 | -$784.13K derived: sum of 2 quarters · filed 2020-12-30 | -$825.02K derived: sum of 3 quarters · filed 2020-12-30 | -$892.33K derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-09-30 | -$656.53K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | -$697.42K derived: sum of 2 quarters · filed 2019-12-23 | -$764.73K derived: sum of 3 quarters · filed 2019-12-23 | -$731.39K 10-K/A · filed 2019-12-23 |
| 2018-06-30 | -$40.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$108.20K derived: sum of 2 quarters · filed 2019-08-14 | -$74.86K 10-Q · filed 2019-08-14 | -$72.08K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$67.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | -$33.97K 10-Q · filed 2019-05-14 | -$31.19K derived: sum of 3 quarters · filed 2019-05-14 | $392.89K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $33.34K 10-Q · filed 2019-02-14 | $36.12K derived: sum of 2 quarters · filed 2019-02-14 | $460.20K derived: sum of 3 quarters · filed 2019-02-14 | $650.57K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | $2.78K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $426.86K derived: sum of 2 quarters · filed 2018-12-19 | $617.22K derived: sum of 3 quarters · filed 2018-12-19 | $558.03K 10-K · filed 2018-12-19 |
| 2017-06-30 | $424.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $614.45K derived: sum of 2 quarters · filed 2018-08-14 | $555.25K 10-Q · filed 2018-08-14 | $758.95K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $190.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $131.17K 10-Q · filed 2018-05-15 | $334.87K derived: sum of 3 quarters · filed 2018-05-15 | -$138.68K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$59.20K 10-Q · filed 2018-02-12 | $144.50K derived: sum of 2 quarters · filed 2018-02-12 | -$329.04K derived: sum of 3 quarters · filed 2018-02-12 | -$49.13K derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | $203.70K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$269.85K derived: sum of 2 quarters · filed 2017-12-29 | $10.06K derived: sum of 3 quarters · filed 2017-12-29 | $290.10K 10-K · filed 2017-12-29 |
| 2016-06-30 | -$473.55K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | -$193.63K derived: sum of 2 quarters · filed 2017-12-11 | $86.40K 10-Q/A · filed 2017-12-11 | -$255.03K derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $279.91K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $559.94K 10-Q/A · filed 2017-12-11 | $218.52K derived: sum of 3 quarters · filed 2017-12-11 | $149.32K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $280.03K 10-Q/A · filed 2017-12-11 | -$61.39K derived: sum of 2 quarters · filed 2017-12-11 | -$130.59K derived: sum of 3 quarters · filed 2017-12-11 | -$301.60K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | -$341.43K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$410.63K derived: sum of 2 quarters · filed 2017-12-11 | -$581.63K derived: sum of 3 quarters · filed 2017-12-11 | -$458.63K 10-K/A · filed 2017-12-11 |
| 2015-06-30 | -$69.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$240.21K derived: sum of 2 quarters · filed 2016-08-09 | -$117.21K 10-Q · filed 2016-08-09 | $60.31K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-03-31 | -$171.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | -$48.01K 10-Q · filed 2016-05-10 | $129.51K derived: sum of 3 quarters · filed 2017-12-11 | -$1.41K derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-12-31 | $123.00K 10-Q · filed 2016-02-09 | $300.51K derived: sum of 2 quarters · filed 2017-12-11 | $169.59K derived: sum of 3 quarters · filed 2017-12-11 | $323.81K derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-09-30 | $177.51K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $46.59K derived: sum of 2 quarters · filed 2017-12-11 | $200.81K derived: sum of 3 quarters · filed 2017-12-11 | $433.71K 10-K/A · filed 2017-12-11 |
| 2014-06-30 | -$130.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $23.29K derived: sum of 2 quarters · filed 2015-08-07 | $256.20K 10-Q · filed 2015-08-07 | -$34.12K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $154.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $387.12K 10-Q · filed 2015-05-08 | $96.80K derived: sum of 3 quarters · filed 2015-12-11 | $449.03K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $232.91K 10-Q · filed 2015-02-06 | -$57.41K derived: sum of 2 quarters · filed 2015-12-11 | $294.82K derived: sum of 3 quarters · filed 2015-12-11 | $311.65K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | -$290.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $61.91K derived: sum of 2 quarters · filed 2015-12-11 | $78.74K derived: sum of 3 quarters · filed 2015-12-11 | $102.00K 10-K · filed 2015-12-11 |
| 2013-06-30 | $352.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | $369.06K derived: sum of 2 quarters · filed 2014-08-08 | $392.31K 10-Q · filed 2014-08-08 | $389.82K derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-03-31 | $16.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $40.08K 10-Q · filed 2014-05-12 | $37.59K derived: sum of 3 quarters · filed 2014-12-23 | $40.10K derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-12-31 | $23.25K 10-Q · filed 2014-02-10 | $20.76K derived: sum of 2 quarters · filed 2014-12-23 | $23.27K derived: sum of 3 quarters · filed 2014-12-23 | $8.84K derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-09-30 | -$2.49K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $13.00 derived: sum of 2 quarters · filed 2014-12-23 | -$14.42K derived: sum of 3 quarters · filed 2014-12-23 | -$99.01K 10-K · filed 2014-12-23 |
| 2012-06-30 | $2.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | -$11.92K derived: sum of 2 quarters · filed 2013-08-09 | -$96.51K 10-Q · filed 2013-08-09 | -$2.53K derived: sum of 4 quarters · filed 2013-12-27 |
| 2012-03-31 | -$14.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | -$99.02K 10-Q · filed 2013-05-10 | -$5.04K derived: sum of 3 quarters · filed 2013-12-27 | -$11.98M derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-12-31 | -$84.59K 10-Q · filed 2013-02-08 | $9.39K derived: sum of 2 quarters · filed 2013-12-27 | -$11.96M derived: sum of 3 quarters · filed 2013-12-27 | $51.28K derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-09-30 | $93.98K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$11.88M derived: sum of 2 quarters · filed 2013-12-27 | $135.87K derived: sum of 3 quarters · filed 2013-12-27 | $147.92K 10-K · filed 2013-12-27 |
| 2011-06-30 | -$11.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | $41.88K derived: sum of 2 quarters · filed 2012-08-09 | $53.94K 10-Q · filed 2012-08-09 | $63.73K derived: sum of 4 quarters · filed 2012-12-14 |
| 2011-03-31 | $12.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | $12.03M 10-Q · filed 2012-05-10 | $12.04M derived: sum of 3 quarters · filed 2012-12-14 | |
| 2010-12-31 | $12.05K 10-Q · filed 2012-02-09 | $21.84K derived: sum of 2 quarters · filed 2012-12-14 | ||
| 2010-09-30 | $9.79K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | $125.03K 10-K · filed 2012-12-14 | ||
| 2010-06-30 | $115.24K 10-Q · filed 2011-08-09 | |||
| 2009-09-30 | -$14.51K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |